EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

N‐acetylcysteine ameliorates hematuria‐associated tubulointerstitial injury in 5/6 nephrectomy mice

Ajay Medipally, Min Xiao, Anjali A Satoskar, Laura Biederman, Alana Dasgupta, Iouri Ivanov, Galina Mikhalina, Brad Rovin, Sergey V Brodsky iD

Physiological Reports · 2023

DOI: 10.14814/phy2.15767 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Physiological Reports, 2023. Verfasst von Ajay Medipally und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Acetylcysteine, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease (CKD) is characterized by increased interstitial fibrosis and tubular atrophy (IFTA) in the kidney. Chronic hematuria is a hallmark of several human kidney diseases and often is seen in patients on anticoagulation therapy. We had previously demonstrated that chronic hematuria associated with warfarin increases IFTA in 5/6 nephrectomy (5/6NE) rats, and such treatment increases reactive oxygen species (ROS) in the kidney. The goal of this study was to evaluate the effects of the antioxidant N‐acetylcysteine (NAC) on the progression of IFTA in 5/6NE mice. 5/6NE C57BL/6 and 5/6NE 129S1/SvImJ mice were treated with warfarin alone or with warfarin and NAC for 23 weeks. Serum creatinine (SCr), hematuria, blood pressure (BP), and ROSs in the kidney were measured; kidney morphology was evaluated. Warfarin doses were titrated to achieve prothrombin time (PT) increase to the levels seen with therapeutic human doses. Warfarin treatment resulted in an increased SCr, systolic BP, hematuria, expression of TGF‐ß and ROS in the kidney in both mouse strains. Tumor necrosis factor alpha (TNF‐ɑ) levels in the serum were increased in 5/6NE mice treated with warfarin. IFTA was increased as compared with control 5/6NE mice, and this increase in IFTA was more prominent in 129S1/SvImJ than in C57BL/6 mice. NAC ameliorated the warfarin‐associated increase in SCr and BP but not hematuria. IFTA, TGF‐ß, and ROS in the kidney as well as TNF‐ɑ levels in the serum were reduced in mice treated with NAC and warfarin as compared to mice treated with warfarin alone. NAC mitigates the increase in SCr and IFTA in mice with chronic hematuria by reducing oxidative stress in the kidney. This data open novel possibilities for treatments in CKD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetylcysteineRenal Insufficiency, ChronicHumansMiceRatsAnimalsWarfarinReactive Oxygen SpeciesTumor Necrosis Factor-alphaMice, Inbred C57BLKidneyNephrectomyHematuriaFibrosis

Stichwörter der Autor:innen

5/6 nephrectomyN-acetylcysteineinterstitial fibrosismouse strain

Substanzen

AcetylcysteineWarfarinReactive Oxygen SpeciesTumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
  • Department of Pathology, Nationwide Children's Hospital, Columbus, Ohio, USA.
  • Rochester Regional Health Nephrology, Rochester, New York, USA.
  • Department of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.

ORCID-Profile: Sergey V Brodsky

Förderung

  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Medipally, A., Xiao, M., Satoskar, A. A., Biederman, L., Dasgupta, A., Ivanov, I., Mikhalina, G., Rovin, B., & Brodsky, S. V. (2023). N‐acetylcysteine ameliorates hematuria‐associated tubulointerstitial injury in 5/6 nephrectomy mice. Physiological Reports. https://doi.org/10.14814/phy2.15767

Vancouver

Medipally A, Xiao M, Satoskar AA, Biederman L, Dasgupta A, Ivanov I, et al. N‐acetylcysteine ameliorates hematuria‐associated tubulointerstitial injury in 5/6 nephrectomy mice. Physiological Reports. 2023. doi:10.14814/phy2.15767

BibTeX
@article{Medipally2023,
  author = {Medipally, Ajay and Xiao, Min and Satoskar, Anjali A and Biederman, Laura and Dasgupta, Alana and Ivanov, Iouri and Mikhalina, Galina and Rovin, Brad and Brodsky, Sergey V},
  title = {N‐acetylcysteine ameliorates hematuria‐associated tubulointerstitial injury in 5/6 nephrectomy mice},
  journal = {Physiological Reports},
  year = {2023},
  doi = {10.14814/phy2.15767}
}
Kostenlos starten →